FDA OKs Omalizumab (Xolair) for Chronic HivesFDA OKs Omalizumab (Xolair) for Chronic Hives

Omalizumab is indicated for people aged 12 years or older with chronic idiopathic urticaria who fail to find relief with antihistamines. FDA Approvals
Source: Medscape Today Headlines - Category: Consumer Health News Tags: Allergy & Clinical Immunology News Alert Source Type: news